BIOTRONIK ILIVIA NEO 7 VR-T DF-1 ProMRI, REF 429531, UDI: 04035479156763 - Product Usage: intende...
FDA Device Recall #Z-1462-2021 — Class II — March 8, 2021
Recall Summary
| Recall Number | Z-1462-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 8, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | BIOTRONIK Inc |
| Location | Lake Oswego, OR |
| Product Type | Devices |
| Quantity | 74 UNITS |
Product Description
BIOTRONIK ILIVIA NEO 7 VR-T DF-1 ProMRI, REF 429531, UDI: 04035479156763 - Product Usage: intended to provide ventricular tachycardia pacing and ventricular defibrillation for automatic treatment of life-threatening ventricular arrhythmias.
Reason for Recall
There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Distribution Pattern
US: Nationwide OUS: Worldwide
Lot / Code Information
Serial Number 61091508 84702943 84730466 84730467 84730473 84731681 84732041 84733171 84733182 84733184 84733566 84733567 84733573 84733576 84733579 84733584 84733789 84733797 84734087 84734093 84734876 84734877 84735634 84735637 84735639 84735642 84737565 84737572 84737578 84737923 84738280 84738281 84738284 84738617 84738620 84738621 84739042 84739049 84739285 84739288 84740027 84740029 84740529 84740981 84741287 84741300 84741301 84741302 84741423 84741558 84741561 84741739 84741883 84741898 84742256 84742261 84743460 84743463 84743908 84743932 84744353 84746458 84746479 84749728 84749736 84753258 84754939 84755554 84755839 84756402 84756412 84761217 84761486 84761780
Other Recalls from BIOTRONIK Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1443-2021 | Class II | BIOTRONIK Ilestro 7 VR-T, DF-1, REF 383578, UDI... | Mar 8, 2021 |
| Z-1445-2021 | Class II | BIOTRONIK Ilestro 7 VR-T DX, DF-1, REF 383594, ... | Mar 8, 2021 |
| Z-1454-2021 | Class II | BIOTRONIK INVENTRA 7, HF-T QP DF4 IS4, REF 393... | Mar 8, 2021 |
| Z-1464-2021 | Class II | BIOTRONIK ILIVIA NEO 7 DR-T DF-1 ProMRI, REF 42... | Mar 8, 2021 |
| Z-1452-2021 | Class II | BIOTRONIK ITREVIA 7, VR-T DF-4, REF 393041, UDI... | Mar 8, 2021 |
Frequently Asked Questions
Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.